Utilizing Artificial Intelligence in Liver Cancer Treatment: A Breakthrough Study
[오늘의 건강] Posted on 04.23.2024 at 06.10 Posted on 04.23.2024 at 06.10 Modified on 04.23.2024 at 09.10 Views 982 Recently, a national research team used artificial intelligence (AI) to develop a system that suggests treatment methods for each liver cancer patient and predicts survival rates. [사진=게티이미지뱅크]On Tuesday 23rd there will be many clouds at times […]
HLB liver cancer treatment Rivoceranib passes the 9th mark for US approval, Jinyanggon speeds up commercialization
[비즈니스포스트] Jin Yang-gon, Chairman of HLB Group, has reached the final hurdle of achieving results with the liver cancer treatment drug Rivoceranib. Since the US Food and Drug Administration (FDA)’s new drug approval process was completed without any particular problems, all that remains is to wait for approval. Jinyanggon commercialization speed battle” height=”150″ src=” width=”300″ […]
